← Leaderboards
Mary Ellen Irene Koran
Vanderbilt University Medical Center
$486,000
Attributed
$486,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $243K · FY2024–25$250K$187.5K$125K$62.5K$0
'24
'25
Funding mix
By agency
NIH$486,000 · 1
By mechanism
K76$486,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- Matthew Schrag$7,278,640
- Jonathan Andrew Kropski$8,175,666
- Anna R Hemnes$10,524,693
- Evan L Brittain$13,630,303
- Kristin Poole O'Grady$1,827,717
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposAbeta ClearanceBiological SexAge YearsAge EffectAlgorithmsAge Of OnsetAlzheimerâS Disease BiomarkerAmyloidAmyloid Beta-ProteinAgingAreaArtificial IntelligenceBiologicalAffectBiologyBrainCandidate Disease GeneCareerCareer DevelopmentCause Of DeathCessation Of LifeClinical DiagnosisClinical Heterogeneity
Grant awards (3)
Genetic architecture of age of onset of amyloid positivity: Integrating imaging and genetic tools to identify novel drivers of disease$243,000
K76 · FY2025 · AG · contact PI
Genetic architecture of age of onset of amyloid positivity: Integrating imaging and genetic tools to identify novel drivers of disease$242,999
K76 · FY2024 · AG · contact PI
Genetic architecture of age of onset of amyloid positivity: Integrating imaging and genetic tools to identify novel drivers of disease$1
K76 · FY2024 · AG · contact PI